Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV and Tuberculosis Co-infection”

57 trials

Showing 20 of 57 results

Not applicableStudy completedNCT03800394
What this trial is testing

Pharmacokinetics of Intracellular TFV-DP and FTC-TP in HIV-infected Adolescents

Who this might be right for
Human Immunodeficiency Virus (HIV)TuberculosisCoinfection
University of Florida 52
Not applicableStudy completedNCT00604617
What this trial is testing

Interferon-Gamma Release Assays in Tuberculosis (TB) - HIV Co-infected Children

Who this might be right for
TuberculosisHIV
Case Western Reserve University 564
Not applicableStudy completedNCT03711721
What this trial is testing

Nutritional Support for HIV-Tuberculosis Co-infected Adults in Senegal, West Africa

Who this might be right for
HIV and Tuberculosis Co-infection
University of Washington 26
Testing effectiveness (Phase 2)Study completedNCT00411996
What this trial is testing

The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin

Who this might be right for
HIV InfectionsTuberculosis
The HIV Netherlands Australia Thailand Research Collaboration 20
Large-scale testing (Phase 3)Study completedNCT00483054
What this trial is testing

Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin

Who this might be right for
HIV InfectionsTuberculosis
Bamrasnaradura Infectious Diseases Institute 142
Large-scale testing (Phase 3)Study completedNCT00398996
What this trial is testing

Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients

Who this might be right for
HIV InfectionsTuberculosis
Centre for the AIDS Programme of Research in South Africa 642
Not applicableStudy completedNCT06608069
What this trial is testing

Pharmacist-Led Intervention to Improve TB Treatment Adherence

Who this might be right for
Tuberculosis, PulmonaryHIV Coinfection
Universiti Sains Malaysia 383
Testing effectiveness (Phase 2)UnknownNCT01986543
What this trial is testing

Interaction Between High Dose Rifampicine and Efavirenz in Pulmonary Tuberculosis and HIV Co-infection

Who this might be right for
TuberculosisHIV
ANRS, Emerging Infectious Diseases 105
Not applicableActive Not RecruitingNCT02129244
What this trial is testing

A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection Outcomes

Who this might be right for
MDR-TBHIV
Johns Hopkins University 3,600
Not applicableStudy completedNCT05452616
What this trial is testing

Same-day Versus Rapid ART Initiation in HIV-positive Individuals Presenting With Symptoms of Tuberculosis

Who this might be right for
Human Immunodeficiency Virus (HIV) Infection
University Hospital, Basel, Switzerland 610
Large-scale testing (Phase 3)UnknownNCT04513379
What this trial is testing

Efficacy of 400 mg Efavirenz Versus Standard 600 mg Dose in HIV/TB Co-infected Patients

Who this might be right for
HIV InfectionsTuberculosis
Shanghai Public Health Clinical Center 80
Testing effectiveness (Phase 2)UnknownNCT00474435
What this trial is testing

Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis

Who this might be right for
TuberculosisHIV Infections
African Poverty Related Infection Oriented Research Initiative 30
Not applicableStudy completedNCT00091936
What this trial is testing

Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 592
Testing effectiveness (Phase 2)Study completedNCT04930744
What this trial is testing

Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)

Who this might be right for
TuberculosisPulmonary TuberculosisHIV Coinfection
University of Massachusetts, Worcester 112
Not applicableStudy completedNCT04972903
What this trial is testing

Impact of Malnutrition on Pharmacokinetic of Rifampicin, Isoniazid, Pyrazinamide and Ethambutol in TB-HIV Co-infected Children (TB-Speed TB-PK)

Who this might be right for
TuberculosisPulmonary
Institut National de la Santé Et de la Recherche Médicale, France 85
Testing effectiveness (Phase 2)Study completedNCT00023413
What this trial is testing

TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz

Who this might be right for
HIV InfectionsTuberculosis
Centers for Disease Control and Prevention 20
Not applicableStudy completedNCT01539005
What this trial is testing

Tuberculosis Recurrence Upon Treatment With Highly Active Antiretroviral Therapy

Who this might be right for
Tuberculosis
Centre for the AIDS Programme of Research in South Africa 402
Large-scale testing (Phase 3)Study completedNCT00495326
What this trial is testing

Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)

Who this might be right for
TuberculosisAidsHiv Infections
French National Agency for Research on AIDS and Viral Hepatitis 570
Large-scale testing (Phase 3)Study completedNCT02178592
What this trial is testing

Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 113
Testing effectiveness (Phase 2)Study completedNCT02412436
What this trial is testing

PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB

Who this might be right for
HIV-1 InfectionTuberculosis
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 62
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation